neutral
mab
consid
potenti
therapeut
approach
prevent
treatment
chronic
acut
viral
infect
includ
newli
emerg
viral
infect
recent
year
dramat
increas
develop
new
mab
improv
neutral
activ
notabl
addit
antirespiratori
syncyti
viru
rsv
mab
use
treat
infant
respiratori
diseas
sever
mab
direct
human
cytomegaloviru
hiv
influenza
ebola
rabi
viru
current
engag
promis
clinic
trial
direct
effect
antivir
mab
viral
propag
studi
extens
littl
attent
paid
potenti
immunomodulatori
effect
recent
use
mous
model
persist
retrovir
infect
ie
erythroleukemia
induc
murin
leukemia
viru
frcase
shown
treatment
infect
mice
highli
neutral
mab
induc
lifelong
protect
immun
vaccinelik
effect
see
ref
observ
may
major
therapeut
implic
human
inde
increas
antivir
immun
respons
mab
treatment
recent
observ
preclin
model
hiv
rsv
henipaviru
infect
see
ref
moreov
passiv
immunotherapi
broadli
neutral
mab
stimul
antivir
antibodi
respons
patient
similarli
vaccinelik
effect
also
document
preclin
model
cancer
immunotherapi
well
clinic
trial
use
antiegfr
mab
yet
neither
mechan
play
possibl
longterm
protect
consequ
address
clinic
trial
human
technic
ethic
cost
limit
strongli
limit
investig
instead
immunocompet
anim
offer
possibl
identifi
cellular
molecular
actor
involv
induct
vaccinelik
effect
antivir
mab
frcaseinduc
erythroleukemia
model
system
permit
extens
analysi
endogen
immun
respons
passiv
mabbas
immunotherapi
condit
chronic
infect
patholog
develop
found
treatment
frcaseinfect
mice
neutral
mab
recogn
retrovir
envelop
use
mous
retrovir
model
shown
mabbas
immunotherapi
induc
lifelong
endogen
protect
immun
vaccinelik
effect
observ
potenti
import
consequ
treat
lifethreaten
human
viral
infect
investig
role
neutrophil
effect
neutrophil
innat
immun
effector
cell
wellestablish
microbekil
activ
rapidli
mobil
upon
infect
also
emerg
orchestr
innat
adapt
immun
howev
immunomodulatori
activ
antivir
mab
immunotherapi
never
studi
data
reveal
neutrophil
essenti
role
immunotherapyinduc
immun
protect
infect
mice
unexpectedli
neutrophil
limit
effect
control
viral
propag
upon
passiv
immunotherapi
administr
mostli
mediat
nk
cell
instead
neutrophil
oper
essenti
induc
potent
host
humor
antivir
respons
thu
neutrophil
play
unexpect
key
role
protect
immun
induct
antivir
mab
work
open
approach
improv
antivir
immunotherapi
suggest
preserv
neutrophil
function
count
might
requir
achiev
mabinduc
protect
immun
glycoprotein
env
shortli
infect
provid
longlast
protect
antivir
immun
type
enhanc
humor
cytotox
cell
ctl
respons
reduc
regulatori
cell
activ
immunomodulatori
action
mab
depend
abil
interact
receptor
igg
notabl
immun
complex
ic
form
administ
mab
viral
determin
enhanc
antivir
ctl
respons
bind
dc
importantli
interact
concern
sever
innat
effector
cell
dc
includ
neutrophil
rapidli
recruit
site
infect
long
view
simpl
direct
scaveng
extracellular
pathogen
recent
evid
neutrophil
key
cell
orchestr
innat
adapt
immun
via
interact
differ
myeloid
lymphoid
cell
modul
function
howev
role
antivir
immun
still
larg
unknown
inde
investig
studi
neutrophil
function
viral
pathogenesi
control
viral
propag
effector
function
ie
phagocytosi
reactiv
oxygen
speci
product
neutrophil
extracellular
trap
format
etc
contrast
immunomodulatori
properti
neutrophil
poorli
studi
viral
infect
address
context
antivir
immunotherapi
use
frcase
model
address
gener
question
neutrophil
particip
induct
protect
immun
antivir
mab
found
essenti
protect
infect
mabtreat
mice
unexpectedli
unlik
nk
cell
neutrophil
limit
effect
viral
propag
control
instead
protect
effect
reli
capac
induc
potent
humor
respons
due
acquisit
b
cell
helper
activ
upon
mab
treatment
find
facilit
improv
design
mabbas
antivir
therapi
suggest
preserv
neutrophil
function
count
might
requir
achiev
optim
protect
mab
neutrophil
necessari
protect
mice
infect
antivir
mab
without
effect
viral
propag
first
address
neutrophil
mobil
frcaseinfect
mice
without
mab
treatment
infectedtr
vs
infectednontr
passiv
immunotherapi
administ
day
establish
viral
infect
figur
day
postinfect
pi
agematch
naiv
mice
use
control
neutrophil
recruit
assess
spleen
one
virem
organ
day
pi
viral
replic
maxim
infectednontr
mice
neutrophil
abund
infectedtr
mice
compar
observ
naiv
mice
wherea
significantli
higher
infectednontr
anim
figur
interestingli
increas
neutrophil
frequenc
associ
higher
percentag
infect
spleen
cell
figur
assess
flow
cytometri
use
antibodi
recogn
gag
protein
epitop
express
surfac
frcaseinfect
cell
next
assess
role
neutrophil
control
viral
propag
well
protect
leukemia
infect
mice
without
mab
treatment
end
neutrophil
deplet
administ
mab
direct
specif
cell
surfac
marker
isotyp
control
mab
deplet
start
day
infect
figur
effici
specif
supplement
figur
supplement
materi
avail
onlin
articl
http
maintain
day
ie
time
necessari
elimin
therapeut
mab
neutrophil
elimin
acceler
diseas
develop
infectednontr
mice
drastic
reduc
protect
provid
mab
infect
mice
figur
next
assess
viral
propag
differ
group
mice
infectednontr
anim
neutrophil
deplet
figur
associ
signific
increas
percentag
infect
spleen
cell
day
figur
pi
supplement
figur
well
higher
viremia
supplement
figur
contrast
infect
treat
mice
viral
propag
significantli
affect
day
figur
pi
figur
supplement
figur
upon
neutrophil
deplet
remain
lower
infectednontr
mice
suggest
viral
control
mab
involv
innat
immun
effector
cell
thu
neutrophil
exert
differ
antivir
effect
frcaseinfect
mice
depend
immunotherapi
anim
undergo
simpl
infect
neutrophil
particip
control
viral
propag
instead
infectedtr
mice
crucial
immunotherapi
period
gener
longterm
protect
leukemia
despit
limit
effect
viral
propag
nk
cell
control
viral
propag
infectedtr
mice
nk
cell
exert
antibodydepend
cellular
cytotox
adcc
activ
infect
cell
expos
determin
retrovir
env
protein
ask
whether
nk
cell
involv
control
viral
propag
infectedtr
mice
end
nk
cell
deplet
use
antibodi
figur
contrast
neutrophil
deplet
absenc
nk
cell
infectedtr
mice
led
significantli
increas
viral
propag
day
pi
figur
next
compar
mabmedi
adcc
activ
nk
cell
neutrophil
infect
cell
use
vivo
antibodymedi
kill
assay
reli
administr
mabopson
frcaseinfect
splenocyt
naiv
mice
figur
deplet
nk
cell
neutrophil
led
reduc
mabmedi
infect
cell
lysi
figur
final
nk
cell
crucial
viral
propag
control
immunotherapi
period
assess
role
protect
leukemia
infectedtr
mice
importantli
nk
cell
deplet
drastic
reduc
surviv
immunotr
mice
figur
indic
antibodymedi
control
viral
propag
nk
cell
necessari
longterm
antivir
protect
thu
nk
cell
crucial
protect
infectedtr
mice
via
effici
control
viral
propag
mabmedi
adcc
neutrophil
differenti
alter
innat
lymphoid
cell
biolog
infectedtr
infectednontr
mice
innat
lymphoid
cell
ilc
heterogen
popul
immun
cell
includ
nk
cell
naiv
int
mice
treat
either
antineutrophil
control
mab
indic
follow
leukem
death
data
repres
independ
experi
mice
per
group
e
infect
cell
rate
upon
neutrophil
deplet
neutrophil
naiv
int
mice
deplet
indic
infect
splenocyt
assay
c
day
pi
data
repres
independ
experi
mice
per
group
data
express
mean
sem
statist
signific
establish
use
parametr
anova
test
bonferroni
correct
p
p
p
figur
infectedtr
mice
treat
indic
mab
isotyp
control
mab
deplet
neutrophil
infectedtr
mice
treat
indic
antibodi
deplet
nk
cell
b
effect
neutrophil
nk
cell
deplet
viral
spread
infectedtr
mice
percentag
infect
cell
day
pi
spleen
naiv
int
mice
deplet
neutrophil
nk
cell
assess
figur
data
repres
independ
experi
least
mice
per
group
c
vivo
cytolysi
activ
mab
naiv
mice
deplet
neutrophil
nk
cell
splenocyt
noninfect
mice
sp
label
use
vital
dye
cfse
cfse
lo
cell
mix
ratio
splenocyt
infect
mice
infectedsp
label
use
cfse
cfse
hi
cell
preincub
mab
mix
cell
popul
administ
naiv
mice
day
deplet
either
neutrophil
nk
cell
mab
antibodi
respect
cytolysi
quantifi
hour
later
describ
method
section
data
present
mean
sem
independ
experi
least
mice
per
group
statist
signific
establish
use
parametr
anova
test
bonferroni
correct
b
e
effect
nk
cell
deplet
surviv
infect
treat
mice
nk
cell
deplet
indic
follow
leukem
death
data
repres
independ
experi
mice
per
group
statist
signific
establish
use
unpair
student
test
data
express
mean
sem
p
p
p
nk
biolog
affect
neutrophil
first
assess
effect
neutrophil
deplet
nk
cell
end
measur
frequenc
cell
spleen
mice
differ
group
popul
contain
mostli
nk
cell
may
also
includ
subpopul
cell
nk
cell
distinguish
ilc
use
cell
surfac
marker
notabl
cell
supplement
figur
indic
vast
major
cell
spleen
display
nk
phenotyp
shown
figur
cell
recruit
spleen
infectednontr
infect
treat
mice
day
pi
similar
stronger
naiv
mice
also
observ
neutrophil
involv
cell
mobil
infectednontr
mice
infectedtr
naiv
mice
figur
next
assess
frequenc
splenic
ilc
nk
cell
quantifi
express
spleen
cell
popul
lack
common
lymphoid
myeloid
lineageassoci
linassoci
marker
lin
recruit
ilc
spleen
e
vivo
cytolysi
activ
mab
infectedtr
mice
deplet
neutrophil
isotyp
control
mab
administ
mice
adcc
activ
quantifi
day
pi
figur
c
data
repres
least
independ
experi
data
express
mean
sem
statist
signific
establish
use
parametr
anova
test
bonferroni
correct
p
p
p
infectednontr
infectedtr
mice
day
pi
significantli
differ
observ
naiv
mice
figur
addit
neutrophil
deplet
significantli
alter
frequenc
ilc
figur
group
mice
result
show
enhanc
recruit
cell
mostli
nk
cell
infectedtr
infectednontr
mice
effect
neutrophil
depend
latter
also
show
neutrophil
deplet
affect
frequenc
splenic
lin
ilc
agreement
lack
effect
neutrophil
deplet
splenic
ilc
report
experiment
set
better
character
effect
neutrophil
splenic
cell
assess
matur
monitor
express
day
pi
marker
identifi
differ
stage
nk
matur
mice
rel
naiv
mice
infectednontr
infectedtr
mice
show
similar
higher
frequenc
cell
includ
fulli
matur
semimatur
cell
figur
expens
immatur
one
data
shown
moreov
deplet
neutrophil
entail
strong
reduct
frequenc
cell
infectednontr
mice
character
cell
indic
higher
neutrophildepend
product
infectedtr
mice
low
similar
level
naiv
infectednontr
anim
whether
latter
neutrophil
profici
defici
figur
final
assess
whether
neutrophil
affect
adcc
activ
nk
cell
infect
treat
mice
notabl
ablat
neutrophil
alter
mabmedi
adcc
activ
nk
cell
figur
consist
lack
effect
viral
propag
figur
figur
thu
matur
similarli
enhanc
infectedtr
infectednontr
mice
effect
neutrophil
depend
latter
nevertheless
neutrophil
might
particip
function
activ
cell
infectedtr
anim
result
show
neutrophil
modul
secret
capac
infectedtr
mice
neutrophil
crucial
induc
humor
cell
antivir
respons
immunotherapytr
mice
sinc
neutrophil
exert
control
viral
propag
immunotherapi
period
figur
figur
necessari
longterm
protect
mice
figur
ask
whether
could
key
induct
vaccinelik
effect
first
address
cellular
adapt
immun
assay
primari
virusspecif
cell
respons
infectednontr
infectedtr
mice
peak
ie
day
pi
without
neutrophil
deplet
consist
previou
work
infectedtr
mice
show
increas
virusspecif
cell
respons
rel
infectednontr
mice
neither
case
frequenc
virusspecif
cell
alter
neutrophil
deplet
figur
similarli
neither
case
show
differ
frequenc
cell
express
figur
data
rule
major
role
neutrophil
mabinduc
antivir
cell
respons
next
address
humor
immun
infectednontr
infectedtr
mice
deplet
neutrophil
achiev
antifrcas
serum
ig
mice
differ
group
assay
elisa
virusspecif
igm
titer
assay
day
pi
ie
peak
igm
respons
upon
frcase
infect
mab
treatment
supplement
figur
significantli
differ
infectednontr
infectedtr
mice
figur
interestingli
neutrophil
deplet
alter
virusspecif
igm
titer
either
infectednontr
infectedtr
mice
figur
agreement
publish
studi
experiment
set
absenc
neutrophil
affect
level
igm
contrari
consist
previou
work
infectedtr
mice
display
much
higher
level
antifrcas
igg
infectednontr
anim
figur
peak
day
pi
still
high
level
end
experi
interestingli
absenc
neutrophil
serum
concentr
antivir
igg
dramat
decreas
infect
treat
mice
figur
supplement
figur
contrast
neutrophil
show
role
regul
poor
nonprotect
antibodi
respons
elicit
infectednontr
mice
figur
importantli
high
antifrcas
igg
seric
level
correl
longer
surviv
time
support
role
high
humor
antivir
respons
protect
diseas
figur
character
longterm
virusspecif
humor
respons
test
whether
infectedtr
mice
deplet
neutrophil
could
respond
viru
challeng
perform
month
first
infect
ie
time
point
primari
humor
respons
strongli
declin
infectedtr
mice
deplet
neutrophil
inocul
frcase
serum
sampl
collect
week
later
assay
gener
endogen
antifrcas
antibodi
presenc
neutrophil
infectedtr
mice
show
increas
virusspecif
humor
respons
figur
absenc
neutrophil
none
infectedtr
mice
respond
viral
challeng
altogeth
result
show
neutrophil
deplet
earli
time
point
infect
treatment
affect
humor
immun
effect
primari
memori
virusspecif
b
cell
respons
margin
zone
mz
b
cell
known
contribut
mount
antibodi
respons
function
might
modul
neutrophil
next
address
frequenc
splenic
mz
hi
igm
hi
cell
follicular
fo
igm
lo
cell
b
cell
mz
b
cell
frequenc
enhanc
neutrophildepend
manner
infectedtr
mice
unchang
infectednontr
anim
rel
naiv
mice
figur
contrast
frequenc
fo
b
cell
significantli
enhanc
infectedtr
mice
rel
naiv
mice
howev
role
neutrophil
figur
interestingli
consist
role
mz
figur
frequenc
frcasespecif
cell
spleen
cell
isol
day
pi
frequenc
virusspecif
cell
total
cell
popul
assay
flow
cytometri
use
b
gagl
mhc
tetram
data
repres
independ
experi
least
mice
per
group
b
express
cell
splenic
cell
analyz
flow
cytometri
express
data
present
repres
independ
experi
least
mice
per
group
data
express
mean
sem
statist
signific
establish
use
parametr
anova
test
bonferroni
correct
p
higher
frequenc
splenic
mz
b
cell
day
pi
infectedtr
mice
associ
higher
frequenc
plasma
cell
bone
marrow
bm
compar
infectednontr
anim
effect
neutrophil
depend
figur
final
histolog
analys
spleen
infect
mice
day
pi
reveal
larger
germin
center
gc
defin
stain
mz
macrophag
cell
infect
treat
versu
infectednontr
mice
figur
agreement
role
neutrophil
enhanc
humor
respons
neutrophil
deplet
infectedtr
mice
led
smaller
gc
figur
thu
neutrophil
essenti
vaccinelik
effect
induc
mab
immunotherapi
stimul
humor
cell
antivir
respons
effect
associ
neutrophildepend
increas
splenic
mz
b
cell
bm
plasma
cell
neutrophil
differ
activ
infectedtr
nontreat
mice
final
address
function
activ
splenic
neutrophil
infect
mice
without
mab
immunotherapi
day
neutrophil
naiv
int
mice
deplet
indic
figur
frcasespecif
igm
level
assay
elisa
day
pi
data
repres
independ
experi
mice
per
group
int
mice
mice
per
group
naiv
mice
b
seric
frcasespecif
igg
concentr
assay
elisa
indic
time
data
repres
independ
experi
mice
per
group
data
express
mean
sem
statist
signific
establish
use
parametr
anova
test
bonferroni
correct
c
correl
serum
antifrcas
igg
level
evalu
auc
surviv
time
analyz
use
pearson
correl
test
auc
evalu
last
time
point
mice
still
aliv
day
pi
infectednontr
n
infectedtr
n
mice
deplet
neutrophil
n
n
respect
show
figur
evalu
correl
frcasespecif
secondari
humor
respons
seric
frcasespecif
igg
level
mice
deplet
neutrophil
assay
elisa
week
viral
challeng
perform
day
pi
data
repres
independ
experi
mice
per
group
statist
signific
establish
use
pair
student
test
p
p
p
pi
monitor
cell
surfac
activ
marker
quantifi
variou
cytokin
mrna
protein
level
infectedtr
infectednontr
mice
splenic
neutrophil
similarli
activ
deduc
shed
increas
express
figur
howev
neutrophil
infectedtr
mice
show
significantli
stronger
express
two
cytokin
involv
b
cell
activ
b
cellactiv
factor
baff
lymphotoxin
compar
infectednontr
anim
figur
suggest
role
therapeut
mab
function
activ
neutrophil
splenic
neutrophil
sort
infectedtr
mice
also
show
trend
higher
secret
capac
baff
compar
infectednontr
mice
neutrophil
even
though
trend
reach
statist
signific
assess
whether
mab
trigger
crosslink
could
enhanc
baff
releas
neutrophil
isol
bm
neutrophil
naiv
mice
stimul
hour
plate
coat
mab
experi
conduct
presenc
absenc
proinflammatori
cytokin
assess
extent
inflammatori
condit
could
synerg
mab
trigger
interestingli
presenc
mab
trigger
led
significantli
increas
releas
baff
neutrophil
figur
summari
frcase
infect
activ
neutrophil
independ
immunotherapi
howev
activ
state
substanti
differ
two
group
anim
notabl
significantli
stronger
express
baff
immunotherapytr
mice
addit
inflammatori
condit
synerg
mabmedi
activ
neutrophil
lead
enhanc
releas
baff
previous
shown
antivir
mabbas
therapi
induc
lifelong
protect
immun
find
potenti
import
therapeut
implic
evid
suggest
may
also
appli
divers
sever
human
viral
diseas
paramount
task
identifi
mechan
origin
mabinduc
vaccinelik
effect
exploit
effici
mabbas
treatment
patient
report
neutrophil
essenti
immunotherapi
period
longterm
surviv
frcaseinfect
mice
control
viral
propag
crucial
induc
baff
releas
bmisol
neutrophil
baff
releas
assess
elisa
supernat
neutrophil
isol
bm
naiv
mice
puriti
cultur
hour
mabcoat
plate
densiti
cell
medium
experi
done
presenc
absenc
proinflammatori
cytokin
ng
ml
mabnonco
plate
use
control
data
repres
independ
experi
data
express
mean
sem
statist
signific
establish
use
parametr
anova
test
bonferroni
correct
c
pair
student
test
b
p
p
p
protect
humor
respons
without
effect
cell
respons
contrast
show
upon
mab
treatment
nk
cell
crucial
elimin
infect
cell
mabmedi
adcc
activ
necessari
longterm
surviv
infectedtr
mice
thu
work
indic
innat
effector
cell
distinct
complementari
role
protect
infect
mice
mab
nk
cell
earli
predomin
role
control
viral
spread
neutrophil
essenti
emerg
potent
host
antivir
humor
respons
find
contrast
current
view
neutrophil
usual
consid
simpl
frontlin
agent
invad
pathogen
highlight
hitherto
unreport
role
neutrophil
key
cell
modul
adapt
antivir
immun
upon
mab
treatment
data
indic
surviv
infectedtr
mice
depend
effici
antifrcas
humor
respons
infectedtr
mice
show
neutrophildepend
increas
frequenc
mz
b
cell
b
enhanc
format
gc
c
increas
plasma
cell
gener
enhanc
product
antivir
igg
interestingli
absenc
neutrophil
immunotherapi
period
infect
mice
also
lead
impair
develop
secondari
humor
respons
upon
viral
challeng
overal
data
suggest
neutrophil
essenti
antivir
protect
due
b
cell
helper
activ
similarli
helper
function
alreadi
document
homeostat
condit
autoimmun
diseasepron
mice
emerg
granulopoiesi
bacteri
infect
importantli
find
show
acquisit
b
cell
helper
function
infect
mice
depend
immunotherapi
modul
antifrcas
humor
respons
detect
infectednontr
mice
upon
neutrophil
deplet
though
exclud
role
factor
studi
suggest
potenti
role
baff
b
cell
helper
function
concern
baff
interest
note
secret
splenic
neutrophil
contribut
activ
splenic
mz
b
cell
acceler
plasma
cell
gener
moreov
baff
administr
mice
increas
frequenc
mz
b
cell
antibodi
product
constitut
signal
mz
b
cell
surviv
differenti
plasmablast
togeth
fact
mz
b
cell
favor
gener
plasma
cell
upon
microbi
infect
reason
specul
baff
induct
neutrophil
infectedtr
mice
may
also
favor
mz
b
cell
respons
subsequ
gener
plasma
cell
interestingli
agreement
vitro
result
show
enhanc
baff
releas
neutrophil
combin
stimul
crosslink
figur
differ
proinflammatori
stimuli
includ
ic
shown
act
secretagogu
synerg
enhanc
baff
secret
human
neutrophil
moreov
neutrophil
deplet
autoimmunitypron
mice
led
reduct
autoantibodi
titer
correl
decreas
serum
level
baff
thu
reason
hypothes
inflammatori
condit
synerg
ic
form
mab
treatment
frcaseinfect
mice
enhanc
baff
releas
neutrophil
although
formal
shown
data
suggest
releas
neutrophil
might
play
role
enhanc
antivir
humor
respons
infectedtr
mice
involv
format
secondari
lymphoid
organ
express
lymphocyt
mediat
larg
varieti
inflammatori
antivir
respons
also
report
play
role
develop
gc
format
requir
igg
respons
show
cytokin
express
releas
neutrophil
upon
mab
treatment
infect
mice
interestingli
although
known
express
neutrophil
propos
nonlymphocyt
murin
splenic
cell
abl
produc
also
report
crosslink
immobil
mab
synerg
enhanc
releas
neutrophil
suggest
similarli
baff
inflammatori
condit
mab
trigger
might
lead
increas
secret
neutrophil
studi
requir
address
whether
baff
combin
action
stimul
antivir
humor
respons
upon
mab
immunotherapi
final
potenti
baff
releas
also
import
assess
whether
neutrophildepend
product
nk
cell
infectedtr
mice
contribut
stimul
antibodi
respons
cytokin
affect
classswitch
longterm
mainten
neutral
antibodi
titer
retrovir
infect
mice
humor
autoimmun
human
identifi
neutrophil
key
player
induct
protect
immun
antivir
mab
import
therapeut
implic
sever
reason
first
combin
therapi
consid
utmost
import
agent
coadminist
passiv
immunotherapi
alter
neutrophil
function
count
avoid
inhibit
effici
antivir
humor
immun
respons
second
patholog
situat
lead
neutropenia
andor
impair
neutrophil
function
certain
viral
infect
andor
druginduc
neutropenia
essenti
restor
could
exampl
achiev
administr
granulocyt
colonystimul
factor
gcsf
cytokin
alreadi
use
clinic
treat
neutropen
patient
interestingli
cytokin
might
also
use
combin
treatment
aim
enhanc
gener
function
neutrophil
furthermor
beyond
stimul
neutrophil
activ
andor
mobil
gcsf
enhanc
neutrophil
baff
secret
capac
therebi
abil
neutrophil
stimul
b
cell
similarli
reduct
viral
load
antiretrovir
therapi
also
permit
partial
restor
impair
function
neutrophil
observ
hivinfect
patient
interestingli
neutrophil
shown
mediat
immunosuppress
via
pathway
hivinfect
patient
antivir
passiv
immunotherapi
might
therefor
benefit
combin
administr
mab
target
immun
checkpoint
final
altern
approach
engin
fc
fragment
antivir
mab
merit
consider
increas
affin
express
neutrophil
might
first
allow
superior
antibodymedi
phagocytosi
recent
report
case
fcmodifi
antihiv
mab
could
alter
cell
signal
cytokinechemokin
product
ultim
lead
effect
adapt
immun
respons
thu
stimul
neutrophil
activ
restor
impair
function
counteract
immunosuppress
action
improv
vaccinelik
effect
antivir
mabbas
immunotherapi
might
also
appli
cancer
treatment
enhanc
antitumor
immun
respons
also
observ
mabbas
anticanc
immunotherapi
import
take
consider
neutrophil
shown
play
role
therapeut
activ
anticanc
mab
mice
mice
bred
maintain
convent
pathogenfre
facil
institut
de
de
montpelli
viral
stock
frcase
viral
stock
produc
assay
store
describ
previous
viral
infect
immunotherapi
mous
followup
eightdayold
mice
infect
ip
viru
suspens
contain
focusform
unit
ffu
treat
mab
hour
pi
day
pi
ip
administr
mice
examin
regular
interv
clinic
sign
erythroleukemia
reduct
hematocrit
euthan
hematocrit
reach
experiment
endpoint
elisa
antifrcas
antibodi
plasma
antifrcas
ig
assay
elisa
previous
describ
peroxidaseconjug
antimous
igg
igm
rabbit
antisera
serotec
use
secondari
antibodi
viru
challeng
experi
infectedtr
mice
deplet
neutrophil
inject
iv
ffuml
frcase
suspens
mix
frcaseinfect
splenocyt
month
first
infect
blood
sampl
collect
week
challeng
assay
endogen
antifrcas
igg
concentr
elisa
vivo
deplet
nk
cell
neutrophil
deplet
administ
rat
antibodi
bioxcel
inject
ip
differ
time
point
isotyp
control
rat
igg
bioxcel
neutrophil
deplet
monitor
flow
cytometri
analysi
hi
cell
nk
cell
deplet
use
antiasialo
antibodi
wako
pure
chemic
industri
ltd
inject
ip
differ
time
point
antibodi
use
studi
vivo
function
nk
cell
mous
strain
lack
allotyp
featur
svev
mice
vivo
cytolysi
activ
experi
conduct
describ
previous
briefli
red
blood
cellfre
splenocyt
recov
frcaseinfect
noninfect
pup
splenocyt
noninfect
mice
label
vital
dye
carboxyfluorescein
succinimidyl
ester
cfse
molecular
probe
concentr
cfse
lo
cell
splenocyt
infect
mice
label
cfse
cfse
hi
cell
preincub
mab
absenc
mab
allow
quantif
spontan
cell
death
cell
popul
mix
ratio
retroorbit
administr
recipi
mice
cytolysi
activ
infect
splenocyt
calcul
ratio
cfse
lo
cfse
hi
cell
spleen
assay
flow
cytometri
hour
later
assess
contribut
nk
cell
neutrophil
antibodymedi
cytolysi
antiasialo
mab
administ
day
prior
assay
flow
cytometri
assay
cell
specif
frcaseinfect
cell
splenocyt
label
apcconjug
cell
antibodi
peconjug
mhc
class
b
tetram
beckman
coulter
display
immunodomin
friend
viru
gagl
epitop
b
gagl
tetram
previous
describ
assay
product
splenocyt
incub
hour
plate
rpmi
cultur
medium
contain
phorbol
ngml
ionomycin
ngml
presenc
brefeldin
milliporesigma
product
assay
flow
cytometri
use
intracellular
cytofixcytoperm
fixationpermeabil
stain
kit
becton
dickinson
histolog
analys
spleen
infectednontr
infectedtr
mice
deplet
neutrophil
recov
day
pi
prepar
previous
describ
briefli
spleen
initi
fix
overnight
paraformaldehydelysineperiod
plp
solut
embed
lowtemperaturegel
agaros
type
milliporesigma
prepar
pb
slice
cut
vibratom
vt
leica
bath
icecold
pb
section
tissu
submerg
pb
transfer
organotyp
cultur
insert
millicel
millipor
stain
becton
dickinson
antibodi
biorad
minut
imag
captur
use
leica
confoc
scan
microscop
rtqpcr
quantif
gene
express
singlecel
suspens
splenocyt
prepar
naiv
infectednontr
infectedtr
mice
day
pi
immunotherapi
neutrophil
hi
express
sort
pure
use
bd
bioscienc
facsaria
devic
rna
extract
sort
neutrophil
use
rneasi
micro
kit
qiagen
rna
qualiti
integr
verifi
use
agil
bioanalyz
cdna
synthes
use
firststrand
kit
qiagen
quantit
pcr
perform
follow
protocol
optim
quantit
profil
pcr
array
use
sybr
green
mix
qiagen
lightcycl
ii
machin
roch
data
normal
result
express
fold
increas
respect
naiv
cell
use
method
baff
protein
releas
quantif
solubl
baff
cellfre
supernat
cultur
neutrophil
assay
use
baff
r
system
elisa
neobiotech
respect
supernat
collect
sort
splenic
neutrophil
naiv
infectednontr
infectedtr
mice
day
pi
immunotherapi
cultur
plate
densiti
cell
well
hour
altern
neutrophil
isol
naiv
mice
bm
use
magneticbas
cell
sort
mac
neutrophil
isol
kit
puriti
miltenyi
biotec
cultur
hour
mabcoat
plate
densiti
cell
medium
presenc
absenc
ngml
mabnonco
plate
use
control
gcsf
r
system
ad
concentr
ngml
neutrophil
cultur
maintain
cell
viabil
statist
statist
analys
perform
use
graphpad
prism
graphpad
softwar
data
express
mean
sem
statist
signific
establish
use
parametr
anova
test
bonferroni
correct
multipl
comparison
unpair
student
test
two
group
compar
p
valu
lower
consid
statist
signific
studi
approv
experiment
procedur
perform
accord
french
nation
anim
care
guidelin
approv
ethic
committe
languedocroussillon
region
montpelli
